针对系统性硬化症相关的间歇性肺部疾病的个性化药物
1Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.
Current treatment options in rheumatology
|April 7, 2025
概括
个性化医疗为患有间歇性肺部疾病 (ILD) 的系统性硬化症 (SSc) 患者提供了新的希望. 生物标志物可以改善诊断,预后和治疗反应,指导个性化护理和临床试验.
科学领域:
- 风湿病学和肺病学 风湿病学和肺病学
- 翻译医学是一种翻译医学.
- 生物标志物发现发现
背景情况:
- 系统性硬化症 (SSc) 是一种罕见的自身免疫性疾病,具有显著的发病率和死亡率.
- 间歇性肺病 (ILD) 是SSc患者的主要死亡原因.
- 目前SSc-ILD的管理在预测疾病进展和设计有效的临床试验方面面临着挑战.
研究的目的:
- 在SSc-ILD.中审查个性化医学的现状.
- 在SSc-ILD中探索个性化医学的未来方向.
- 讨论个性化医疗在SSc-ILD临床试验设计中的应用.
主要方法:
- 现有文献的叙述性审查.
- 分析当前的治疗方法和临床试验设计.
- 鉴定疾病评估的潜在生物标志物.
主要成果:
- 个性化医疗方法对于解决SSc-ILD未满足的需求至关重要.
- 血清,放射和新型生物标志物显示出评估疾病活性和治疗反应的前景.
- 个性化医疗可以促进早期诊断,疾病分层和预后.
结论:
- 个性化医疗具有显著的潜力,可以改善SSc-ILD患者的治疗结果.
- 生物标志物驱动的策略是推动SSc-ILD个性化护理的关键.
- 个性化医学可以提高SSc-ILD临床试验的设计和效率.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
356
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
8.0K
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K